News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
6 | Follower
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
13.07.2024
Dermatology Advisor will be reporting on the latest news and research presented at the 2022 AAD Annual Meeting, from March 25 through March 29.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
12.07.2024
The REMS requirements for Dsuvia® (sufentanil) have recently been modified by the FDA with regard to healthcare setting audits.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
12.07.2024
Products marketed with the names "Artri" or "Ortiga" may contain hidden active drug ingredients that may pose a health risk to patients.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
12.07.2024
An optometrist and dermatologist provide clinical insights into treating ocular and facial rosacea and discuss comanagement strategies.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
17.05.2024
Ascension, a US health care system with 140 hospitals in 19 states, announced a cyberattack has caused disruptions at some of its hospitals.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
15.05.2024
More than 80% of patients with AD treated with upadacitinib had meaningful response rates by week 2, maintained through week 52.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
15.05.2024
Dr Kiya Movassaghi has been appointed President of The Aesthetic Society, with a focus on strengthening it as a worldwide leader in education and innovation.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
15.05.2024
PsA and AD can coexist, and the presence of both conditions may mean special attention should be given to selecting optimal treatment.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
15.05.2024
Heat-related illness ED visits substantially increased in the summer of 2023 vs previous years, especially in men and adults aged 18 to 64.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
11.05.2024
For patients with extramammary Paget disease, rates of local, nodal, and distal recurrence differed depending on anatomic subtype.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
11.05.2024
Access to COVID-19 vaccines in the US through fall 2023 was enabled by a federal partnership that may be a model for future vaccine programs.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
11.05.2024
An AAO-HNS practice guideline identifies areas of quality improvement for clinicians administering immunotherapy for inhalant allergies.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
11.05.2024
The updated 2023-2024 COVID-19 vaccine conferred increased protection against COVID-19-related hospitalization in immunocompromised adults.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
11.05.2024
A recent analysis of the AAV8-based vector GS1196, which expresses human C1-INH for the treatment of HAE, has shown safety in mice and nonhuman primates.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
10.05.2024
Systemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis risk in a dose-response fashion.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
08.05.2024
Preoperative antibiotic exposure in patients with native joint septic arthritis resulted in a significant decrease in microbiologic yield of operative cultures.
Dermatology Advisor - Skin Cancer, Acne, Skin Injury | Dermatology News, Treatment Studies
08.05.2024
Concurrent administration of the bivalent COVID-19 booster and influenza vaccines may yield stronger and longer-lasting SARS-CoV-2 nAb responses.